Clinical Trial Update: A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for OCV-C02 in advanced or relapsed colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OCV-C02

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-02-26